Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Signet Ring Cell Adenocarcinoma”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Large-scale testing (Phase 3)UnknownNCT01226394
What this trial is testing

Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients

Who this might be right for
Colorectal Cancer With a Resected Minimal Synchronous PCOvarian MetastasesTumour Rupture in the Abdominal Cavity
Gustave Roussy, Cancer Campus, Grand Paris 130
Not applicableStudy completedNCT06978595
What this trial is testing

Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies

Who this might be right for
Colorectal CarcinomaCancerSignet Ring Adenocarcinoma of the Colon
asmaa salama ibrahim 8,171
Large-scale testing (Phase 3)UnknownNCT03355612
What this trial is testing

XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma

Who this might be right for
Gastric Carcinoma
Tianjin Medical University Cancer Institute and Hospital 456
Early research (Phase 1)Ended earlyNCT01198535
What this trial is testing

Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer

Who this might be right for
Colon Mucinous AdenocarcinomaColon Signet Ring Cell AdenocarcinomaRectal Mucinous Adenocarcinoma+7 more
National Cancer Institute (NCI) 60
Not applicableLooking for participantsNCT01717924
What this trial is testing

Evaluation of Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma

Who this might be right for
Signet Ring Cell Gastric Adenocarcinoma
University Hospital, Lille 314
Not applicableStudy completedNCT01726296
What this trial is testing

Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care

Who this might be right for
Adenocarcinoma of the LungMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+23 more
Fox Chase Cancer Center 1,440
Testing effectiveness (Phase 2)Study completedNCT01834469
What this trial is testing

Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients

Who this might be right for
Ovarian CancerPeritoneal Carcinomatosis
Jules Bordet Institute 10
Not applicableStudy completedNCT01249859
What this trial is testing

Prognosis of Signet Ring Cells in Upper Digestive Neoplasms

Who this might be right for
Signet Ring Cell CarcinomaStomach DiseaseOesophagus+2 more
University Hospital, Lille 2,500
Testing effectiveness (Phase 2)Ended earlyNCT05001282
What this trial is testing

Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Who this might be right for
Ovarian CancerOvarian NeoplasmsOvarian Carcinoma+22 more
Elucida Oncology 79
Not applicableUnknownNCT06192030
What this trial is testing

Machine Learning Predicts Survival and Mutations in Ovarian Metastases of Colorectal Cancer

Who this might be right for
Ovarian Metastases of Colorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 200
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Not applicableUnknownNCT06182644
What this trial is testing

Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors

Who this might be right for
Renal Cell CarcinomaGastric CancerHepatocellular Carcinoma+3 more
Guangdong Provincial People's Hospital 30
Early research (Phase 1)Study completedNCT01643499
What this trial is testing

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more
University of Chicago 79
Testing effectiveness (Phase 2)Active Not RecruitingNCT05504252
What this trial is testing

METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin

Who this might be right for
Colorectal AdenocarcinomaMucinous AdenocarcinomaSignet Ring Cell Adenocarcinoma
University Hospital, Akershus 80
Testing effectiveness (Phase 2)Ended earlyNCT00745134
What this trial is testing

Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer

Who this might be right for
Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal Carcinoma+6 more
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT01802320
What this trial is testing

Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Who this might be right for
Colon Mucinous AdenocarcinomaColon Signet Ring Cell AdenocarcinomaRectal Mucinous Adenocarcinoma+13 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07091227
What this trial is testing

Efficacy and Safety of AK112 Combined Chemotherapy as Neoadjuvant Treatment for Signet Ring Cell-containing G/GEJ Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
Peking Union Medical College Hospital 66
Not applicableWithdrawnNCT02594943
What this trial is testing

Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer

Who this might be right for
Stomach Neoplasms
Region Skane
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Large-scale testing (Phase 3)Study completedNCT00068692
What this trial is testing

Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer

Who this might be right for
Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal Carcinoma+8 more
National Cancer Institute (NCI) 225
Load More Results